Approvals/CIMA-AEMPS/LEVOSIMENDAN SALA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

LEVOSIMENDAN SALA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Laboratorio Reig Jofre, S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e46144506e040810
Drug Cima Aemps Name: LEVOSIMENDAN SALA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 88919
Holder Company Name: Laboratorio Reig Jofre, S.A.
Marketing Company Name: Laboratorio Reig Jofre, S.A.
Authorization Date: 2023-06-20
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2,5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Laboratorio Reig Jofre, S.A.

LEVOSIMENDAN

2,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 20, 2023

Approval ID

e46144506e040810

Type

Standard